(INVZ) Innoviz Technologies - Overview
Sector: Consumer CyclicalIndustry: Auto Parts | Exchange NASDAQ (USA) | Currency USD | Market Cap: 148m | Total Return -8.5% in 12m
Stock: LiDAR Sensors, Perception Software, Automotive Technology
Total Rating 14
Risk 34
Buy Signal -1.98
| Risk 5d forecast | |
|---|---|
| Volatility | 81.0% |
| Relative Tail Risk | -18.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.30 |
| Alpha | -35.39 |
| Character TTM | |
|---|---|
| Beta | 2.126 |
| Beta Downside | -0.108 |
| Drawdowns 3y | |
|---|---|
| Max DD | 88.12% |
| CAGR/Max DD | -0.48 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: INVZ Innoviz Technologies March 04, 2026
Innoviz Technologies (INVZ) develops and sells LiDAR sensors and perception software for autonomous vehicles. The companys products, like InnovizOne and InnovizTwo, are designed for automotive manufacturers and other autonomous mobility providers.
The automotive LiDAR market is projected to grow significantly as autonomous driving technology advances. Innovizs business model focuses on providing hardware and software solutions to enable various levels of autonomous driving capabilities across different vehicle types.
Innoviz operates globally, with a presence in Europe, Asia Pacific, North America, and other regions. Distribution occurs through direct sales and partnerships.
For more detailed financial analysis and performance metrics, consider researching INVZ on ValueRay.
Headlines to watch out for
- Automaker adoption of LiDAR technology drives revenue growth
- Supply chain disruptions impact production costs and delivery
- Autonomous driving regulations influence market expansion
- Competition from alternative sensor technologies pressures pricing
- Global economic slowdown reduces automotive industry spending
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -67.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.38 > 0.02 and ΔFCF/TA 24.05 > 1.0 |
| NWC/Revenue: 106.7% < 20% (prev 226.0%; Δ -119.3% < -1%) |
| CFO/TA -0.34 > 3% & CFO -47.8m > Net Income -67.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (210.4m) vs 12m ago -4.95% < -2% |
| Gross Margin: 23.43% > 18% (prev -0.05%; Δ 2.35k% > 0.5%) |
| Asset Turnover: 40.73% > 50% (prev 18.38%; Δ 22.35% > 0%) |
| Interest Coverage Ratio: -39.12 > 6 (EBITDA TTM -61.4m / Interest Expense TTM 1.72m) |
Altman Z'' -15.00
| A: 0.42 (Total Current Assets 90.2m - Total Current Liabilities 31.4m) / Total Assets 138.5m |
| B: -5.76 (Retained Earnings -797.8m / Total Assets 138.5m) |
| C: -0.50 (EBIT TTM -67.3m / Avg Total Assets 135.3m) |
| D: -13.14 (Book Value of Equity -797.8m / Total Liabilities 60.7m) |
| Altman-Z'' Score: -33.14 = D |
Beneish M -2.43
| DSRI: 0.71 (Receivables 9.98m/6.15m, Revenue 55.1m/24.3m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.11 (AQ_t 0.02 / AQ_t-1 0.02) |
| SGI: 2.27 (Revenue 55.1m / 24.3m) |
| TATA: -0.14 (NI -67.8m - CFO -47.8m) / TA 138.5m) |
| Beneish M-Score: -2.43 (Cap -4..+1) = BBB |
What is the price of INVZ shares?
As of March 27, 2026, the stock is trading at USD 0.64 with a total of 2,029,408 shares traded.
Over the past week, the price has changed by -8.38%, over one month by -29.49%, over three months by -32.90% and over the past year by -8.53%.
Over the past week, the price has changed by -8.38%, over one month by -29.49%, over three months by -32.90% and over the past year by -8.53%.
Is INVZ a buy, sell or hold?
Innoviz Technologies has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy INVZ.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the INVZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.3 | 256.3% |
| Analysts Target Price | 2.3 | 256.3% |
INVZ Fundamental Data Overview March 23, 2026
P/S = 2.6869
P/B = 1.9051
Revenue TTM = 55.1m USD
EBIT TTM = -67.3m USD
EBITDA TTM = -61.4m USD
Long Term Debt = 35.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 5.95m USD (from shortTermDebt, last quarter)
Debt = 64.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.9m USD (from netDebt column, last quarter)
Enterprise Value = 140.4m USD (148.0m + Debt 64.6m - CCE 72.1m)
Interest Coverage Ratio = -39.12 (Ebit TTM -67.3m / Interest Expense TTM 1.72m)
EV/FCF = -2.70x (Enterprise Value 140.4m / FCF TTM -52.0m)
FCF Yield = -37.03% (FCF TTM -52.0m / Enterprise Value 140.4m)
FCF Margin = -94.41% (FCF TTM -52.0m / Revenue TTM 55.1m)
Net Margin = -123.1% (Net Income TTM -67.8m / Revenue TTM 55.1m)
Gross Margin = 23.43% ((Revenue TTM 55.1m - Cost of Revenue TTM 42.2m) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 15.04%)
Tobins Q-Ratio = 1.01 (Enterprise Value 140.4m / Total Assets 138.5m)
Interest Expense / Debt = 0.43% (Interest Expense 276k / Debt 64.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -53.2m (EBIT -67.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.87 (Total Current Assets 90.2m / Total Current Liabilities 31.4m)
Debt / Equity = 0.83 (Debt 64.6m / totalStockholderEquity, last quarter 77.7m)
Debt / EBITDA = -0.91 (negative EBITDA) (Net Debt 55.9m / EBITDA -61.4m)
Debt / FCF = -1.07 (negative FCF - burning cash) (Net Debt 55.9m / FCF TTM -52.0m)
Total Stockholder Equity = 92.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -50.13% (Net Income -67.8m / Total Assets 138.5m)
RoE = -73.64% (Net Income TTM -67.8m / Total Stockholder Equity 92.1m)
RoCE = -52.87% (EBIT -67.3m / Capital Employed (Equity 92.1m + L.T.Debt 35.3m))
RoIC = -57.76% (negative operating profit) (NOPAT -53.2m / Invested Capital 92.1m)
WACC = 9.48% (E(148.0m)/V(212.6m) * Re(13.46%) + D(64.6m)/V(212.6m) * Rd(0.43%) * (1-Tc(0.21)))
Discount Rate = 13.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 12.89%
[DCF] Fair Price = unknown (Cash Flow -52.0m)
EPS Correlation: 91.72 | EPS CAGR: 41.83% | SUE: -0.49 | # QB: 0
Revenue Correlation: 84.89 | Revenue CAGR: 68.94% | SUE: -0.66 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.08 | Chg7d=-0.017 | Chg30d=-0.017 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=-0.29 | Chg7d=-0.013 | Chg30d=-0.013 | Revisions Net=+0 | Growth EPS=+14.7% | Growth Revenue=+26.8%
EPS next Year (2027-12-31): EPS=-0.23 | Chg7d=+0.017 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+19.5% | Growth Revenue=+47.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
P/B = 1.9051
Revenue TTM = 55.1m USD
EBIT TTM = -67.3m USD
EBITDA TTM = -61.4m USD
Long Term Debt = 35.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 5.95m USD (from shortTermDebt, last quarter)
Debt = 64.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.9m USD (from netDebt column, last quarter)
Enterprise Value = 140.4m USD (148.0m + Debt 64.6m - CCE 72.1m)
Interest Coverage Ratio = -39.12 (Ebit TTM -67.3m / Interest Expense TTM 1.72m)
EV/FCF = -2.70x (Enterprise Value 140.4m / FCF TTM -52.0m)
FCF Yield = -37.03% (FCF TTM -52.0m / Enterprise Value 140.4m)
FCF Margin = -94.41% (FCF TTM -52.0m / Revenue TTM 55.1m)
Net Margin = -123.1% (Net Income TTM -67.8m / Revenue TTM 55.1m)
Gross Margin = 23.43% ((Revenue TTM 55.1m - Cost of Revenue TTM 42.2m) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 15.04%)
Tobins Q-Ratio = 1.01 (Enterprise Value 140.4m / Total Assets 138.5m)
Interest Expense / Debt = 0.43% (Interest Expense 276k / Debt 64.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -53.2m (EBIT -67.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.87 (Total Current Assets 90.2m / Total Current Liabilities 31.4m)
Debt / Equity = 0.83 (Debt 64.6m / totalStockholderEquity, last quarter 77.7m)
Debt / EBITDA = -0.91 (negative EBITDA) (Net Debt 55.9m / EBITDA -61.4m)
Debt / FCF = -1.07 (negative FCF - burning cash) (Net Debt 55.9m / FCF TTM -52.0m)
Total Stockholder Equity = 92.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -50.13% (Net Income -67.8m / Total Assets 138.5m)
RoE = -73.64% (Net Income TTM -67.8m / Total Stockholder Equity 92.1m)
RoCE = -52.87% (EBIT -67.3m / Capital Employed (Equity 92.1m + L.T.Debt 35.3m))
RoIC = -57.76% (negative operating profit) (NOPAT -53.2m / Invested Capital 92.1m)
WACC = 9.48% (E(148.0m)/V(212.6m) * Re(13.46%) + D(64.6m)/V(212.6m) * Rd(0.43%) * (1-Tc(0.21)))
Discount Rate = 13.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 12.89%
[DCF] Fair Price = unknown (Cash Flow -52.0m)
EPS Correlation: 91.72 | EPS CAGR: 41.83% | SUE: -0.49 | # QB: 0
Revenue Correlation: 84.89 | Revenue CAGR: 68.94% | SUE: -0.66 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.08 | Chg7d=-0.017 | Chg30d=-0.017 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=-0.29 | Chg7d=-0.013 | Chg30d=-0.013 | Revisions Net=+0 | Growth EPS=+14.7% | Growth Revenue=+26.8%
EPS next Year (2027-12-31): EPS=-0.23 | Chg7d=+0.017 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+19.5% | Growth Revenue=+47.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)